Our Perspectives

Exploring Alternative Payment Models in Healthcare

For years, the standard method of payment to physicians has been “fee-for-service” (FFS). This method was introduced in the 1930s and refers to paying physicians based on the number of services they provide to patients. Under this model, physicians who provide more services, such as procedures and office visits, would earn more money than...

Read More

Patient-Centric Approaches: A New Era in Healthcare

The Power of Putting Patients First The landscape of healthcare has undergone a significant transformation, with a renewed focus on patient-centered...

Read More

Mind Medicine: The Resurgence of Psychedelic Drugs in Mental Health Care

For hundreds of years, psychedelic drugs have been praised for their medicinal benefits and mind-altering effects. Known also as hallucinogenic,...

Read More

Understanding the Alzheimer's Research and Treatment Landscape: From Challenges to Hope

In the book, “Outlive,” Peter Attia refers to neurodegenerative diseases, such as Alzheimer’s and dementia, as one of the “Four Horsemen” of chronic...

Read More

Telehealth’s Evolution Beyond Pandemic Response: A Comprehensive Outlook

The COVID-19 pandemic acted as a catalyst for the widespread adoption of telehealth. Initially driven by necessity, virtual care rapidly became an...

Read More

Charting the Course: The Rise of Digital Therapeutics in Healthcare

Technological innovation has had an immense impact on healthcare delivery. Novel medical devices and cutting-edge pharmaceuticals continue to...

Read More

Mark Cuban’s Cost Plus Drugs: A Game-Changer in Health Accessibility

The escalating cost of prescription drugs has become a pressing concern for patients, healthcare providers, and policymakers alike. In this landscape...

Read More

Securing the Future: Navigating Challenges and Opportunities in Medicare

Medicare Advantage has been facing criticism for its administrative and financial delays, and an increasing number of hospitals are scrapping their...

Read More

Diversifying Clinical Trials: Navigating the FDA's Roadmap for Inclusive Research

In April 2022, the FDA released draft guidance with recommendations for drug developers and clinical trial researchers. The guidance highlights gaps...

Read More

Shining a Light: Understanding the Complexities of Rare Diseases and Orphan Drug Development

Rare Disease Day will take place on February 29th this year and is a global opportunity to raise awareness for the individuals and families facing...

Read More